AbbVie Inc.Long
IS $ABBV ready to come up on the right side of its base?
Notes:
* Strong up trend on all time frames
* Great earnings track record
* Basing for the past ~8 months
* Now looking to come up on the right side of its base
* Printed a pocket pivot in the last session, indicating institutional buying
* Offering an early entry relative to its 50 day line
Technicals:
Sector: Healthcare - Drug Manufacturers - General
Relative Strength vs. Sector: 6.46
Relative Strength vs. SP500: 2.33
U/D Ratio: 1.4
Base Depth: 28.76%
Distance from breakout buy point: -12.22%
Volume 18.24% above its 15 day avg.
Trade Idea:
* You can enter now as the price is coming off of its 50 day line
* If you're looking for a better entry you can look for one around the ~147 area as that should hold as support moving forward
* If you're looking for a safer entry you can wait for a break and close above the ~152.5 area as that is the immediate resistance coming up
* A daily close below the ~147 area would negate the bullish outlook.
* Strong up trend on all time frames
* Great earnings track record
* Basing for the past ~8 months
* Now looking to come up on the right side of its base
* Printed a pocket pivot in the last session, indicating institutional buying
* Offering an early entry relative to its 50 day line
Technicals:
Sector: Healthcare - Drug Manufacturers - General
Relative Strength vs. Sector: 6.46
Relative Strength vs. SP500: 2.33
U/D Ratio: 1.4
Base Depth: 28.76%
Distance from breakout buy point: -12.22%
Volume 18.24% above its 15 day avg.
Trade Idea:
* You can enter now as the price is coming off of its 50 day line
* If you're looking for a better entry you can look for one around the ~147 area as that should hold as support moving forward
* If you're looking for a safer entry you can wait for a break and close above the ~152.5 area as that is the immediate resistance coming up
* A daily close below the ~147 area would negate the bullish outlook.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.